- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05502328
Radicle Energy: A Study of Cannabinoids on Energy and Other Health Outcomes
Radicle™ Energy: A Randomized, Blinded, Placebo-controlled Study of Cannabinoid Formulations and Their Effects on Energy Levels, Focus, Appetite and Other Health Outcomes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a randomized, blinded, placebo-controlled study conducted with up to 300 adult participants per study arm (3000 total), age 21 and older and residing in the United States.
Eligible participants will (1) endorse a desire for more energy (less fatigue and/or better concentration/focus during screening); (2) indicate a willingness to refrain from taking cannabinoids during the study period, and (3) indicate an interest in taking a plant derived cannabinoid product to help with their energy and/or focus.
Participants with known liver disease, heavy drinkers, and those who are pregnant, trying to become pregnant, or breastfeeding will be excluded. Those taking medications that warn against grapefruit consumption will be excluded. People with a calculated BMI of 18.5 or less will be excluded.
Self-reported data are collected electronically from eligible participants over 5 weeks. Participant reports of health indicators will be collected during baseline, throughout the active period of study product use, and in a final survey. All study assessments will be electronic; there are no in-person visits or assessments for this real-world evidence study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Del Mar, California, United States, 92014
- Radicle Science, Inc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 21 years of age and older
- Resides in the United States
- Endorses: a desire for more energy (less fatigue) and/or a desire for better concentration (focus/attention)
- Selects more energy and/or better concentration as a primary reason for taking a cannabinoid product
- Expresses a willingness to refrain from taking any non-study cannabinoid product (i.e.
CBD, THC) for the duration of participant engagement
- Expresses a willingness to take a study product and not knowing the product identity until the end of the study
Exclusion Criteria:
Pregnant, trying to become pregnant, or breastfeeding Reports a diagnosis of liver disease Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day) Unable to read and understand English Lack of reliable daily access to the internet Reports taking any medication that warns against grapefruit consumption Calculated BMI 18.5 or less
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control 1
Energy Product Form 1 - control
|
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
|
|
Placebo Comparator: Control 2
Energy Product Form 2 - control
|
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
|
|
Experimental: Energy Product 1.1
Energy Product Form 1 - active product 1
|
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
|
|
Experimental: Energy Product 1.2
Energy Product Form 1 - active product 2
|
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
|
|
Experimental: Energy Product 2.1
Energy Product Form 2 - active 1
|
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
|
|
Experimental: Energy Product 2.2
Energy Product Form 2 - active 2
|
Participants will use their Radicle Energy study product as directed for a period of 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in energy
Time Frame: 4 weeks
|
Change in mean energy score as assessed by Patient Reported Outcome Measurement System (PROMIS) Fatigue 7a (scale 1-5; where lower score is less fatigue)
|
4 weeks
|
|
Change in focus
Time Frame: 4 weeks
|
Change in concentration (ability to focus) score as assessed by PROMIS™ Cognition 6a (scale 1-5; where lower score is worse focus (cognitive function))
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in energy (measure 2)
Time Frame: 4 weeks
|
Change in energy level score as assessed by a visual analog scale (VAS; Scoring from 0 to 10, with 0 being 'No energy' and 10 being 'More than enough energy')
|
4 weeks
|
|
Change in body weight
Time Frame: 4 weeks
|
Change in body weight as assessed by self-reported body weight in pounds
|
4 weeks
|
|
Change in appetite
Time Frame: 4 weeks
|
Change in appetite as assessed by a visual appetite scale (VAS; Scoring from 0 to 10, with 0 being 'No hunger' and 10 being 'Always hungry')
|
4 weeks
|
|
Change in overall quality of life (QOL)
Time Frame: 4 weeks
|
Change in QOL score as assessed by Kemp QOL (scale 1-7; with higher scores corresponding to higher quality of life)
|
4 weeks
|
|
Change in overall well-being
Time Frame: 4 weeks
|
Change in well-being score as assessed by World Health Organization 5 Well-being Index (WHO-5 Well-being Index; with higher scores corresponding to greater well-being)
|
4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pain
Time Frame: 4 weeks
|
Change in pain score as assessed by the Pain on average, Enjoyment of life, and General activity Score (PEG; scale 0-10 where 0 is no pain)
|
4 weeks
|
|
Change in Sleep quality
Time Frame: 4 weeks
|
Change in sleep quality (sleep disturbance) score as assessed by the PROMIS Sleep Disturbance 4A (scale 4 to 20; where higher scores correspond to higher levels of sleep disturbance)
|
4 weeks
|
|
Change in feelings of anxiety
Time Frame: 4 weeks
|
Change in anxiety score as assessed by the PROMIS Anxiety 4a (scale 4-20; where higher scores correspond to greater levels of anxiety)
|
4 weeks
|
|
Change in Stress
Time Frame: 4 weeks
|
Change in stress score as assessed by the PROMIS Stress 4a (scale 4-20; where higher scores correspond to greater levels of stress)
|
4 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Emily K Pauli, PharmD, Radicle Science, Inc
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RADX-22D02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Energy
-
Liverpool John Moores UniversityAlliance for Potato Research and EducationCompletedEnergy Supply; Deficiency | Energy Balance | Energy AvailabilityUnited Kingdom
-
Wageningen UniversityTNO; Gelderse Vallei Hospital; Bonumose, Inc.CompletedEnergy Intake | Energy MetabolismNetherlands
-
Institut National de Recherche pour l'Agriculture...Centre de Recherche en Nutrition Humaine Rhone-Alpe; Centre de Recherche en...CompletedEnergy Expenditure | Computer Simulation | Energy MetabolismFrance
-
University of South CarolinaCompleted
-
Shenzhen Institutes of Advanced Technology ,Chinese...RecruitingExercise | Food Preferences | Energy Expenditure | Energy IntakeChina
-
University of BathRoyal Centre for Defence MedicineNot yet recruitingRelative Energy Deficiency in Sport | Energy Balance | Energy Deficit | Low Energy AvailabilityUnited Kingdom
-
Hacettepe UniversityCompletedEnergy Intake | Appetite | Post-exercise | Negative Energy BalanceTurkey (Türkiye)
-
Ori Diagnostic Instruments LLCSuspendedBody Composition | Energy Expenditure | Energy Metabolism | Body FluidsUnited States
-
National Taiwan Normal UniversityRecruitingResistance Exercise | Energy Expenditure | Energy Balance | Males and FemalesTaiwan
-
David Grant U.S. Air Force Medical CenterCompletedEvaluation of Energy Drink Consumption on ECG and Hemodynamic Parameters in Young Healthy VolunteersHemodynamic Effects of Energy Drink | Electrocardiograph Effects of Energy DrinksUnited States
Clinical Trials on Energy Study Product Usage
-
Radicle ScienceCompletedFatigue | EnergyUnited States
-
Radicle ScienceCompletedFatigue | EnergyUnited States
-
Radicle ScienceCompletedSleep Disorder | Sleep | Sleep DisturbanceUnited States
-
Radicle ScienceCompletedPain | Neuropathic Pain | Nociceptive PainUnited States
-
Radicle ScienceCompletedCognitive FunctionUnited States
-
Radicle ScienceCompletedCognitive FunctionUnited States
-
Radicle ScienceCompletedStress | AnxietyUnited States
-
Radicle ScienceCompletedSleep Disorder | Sleep | Sleep DisturbanceUnited States
-
Radicle ScienceCompleted
-
Radicle ScienceCompletedPain | Neuropathic Pain | Nociceptive PainUnited States